These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30407251)

  • 1. Sex differences in HIV-associated cognitive impairment.
    Sundermann EE; Heaton RK; Pasipanodya E; Moore RC; Paolillo EW; Rubin LH; Ellis R; Moore DJ;
    AIDS; 2018 Nov; 32(18):2719-2726. PubMed ID: 30407251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.
    Rubin LH; Springer G; Martin EM; Seaberg EC; Sacktor NC; Levine A; Valcour VG; Young MA; Becker JT; Maki PM
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):274-283. PubMed ID: 30893126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    Rourke SB; Bekele T; Rachlis A; Kovacs C; Brunetta J; Gill MJ; Carvalhal A; Cysique LA; Marcotte T; Power C
    AIDS; 2021 Jan; 35(1):63-72. PubMed ID: 33048883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.
    Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ
    J Neurovirol; 2014 Jun; 20(3):258-68. PubMed ID: 24696363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV.
    Zamudio-Rodríguez A; Belaunzarán-Zamudio PF; Sierra-Madero JG; Cuellar-Rodríguez J; Crabtree-Ramírez BE; Alcala-Zermeno JL; Amieva H; Avila-Funes JA
    AIDS Res Hum Retroviruses; 2018 May; 34(5):449-455. PubMed ID: 29385834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between physical activity and cognition in men with and without HIV infection.
    Monroe AK; Zhang L; Jacobson LP; Plankey MW; Brown TT; Miller EN; Martin E; Becker JT; Levine AJ; Ragin A; Sacktor NC
    HIV Med; 2017 Sep; 18(8):555-563. PubMed ID: 28294530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.
    Tu W; Chen PA; Koenig N; Gomez D; Fujiwara E; Gill MJ; Kong L; Power C
    J Neurovirol; 2020 Feb; 26(1):41-51. PubMed ID: 31520320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
    Asiedu N; Kretchy I; Asampong E
    Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and neuroimaging correlates of cognition in HIV.
    Davies O; Haynes BI; Casey SJ; Gerbase S; Barker GJ; Pitkanen M; Kulasegaram R; Kopelman MD
    J Neurovirol; 2019 Dec; 25(6):754-764. PubMed ID: 31214916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.
    Weber E; Morgan EE; Iudicello JE; Blackstone K; Grant I; Ellis RJ; Letendre SL; Little S; Morris S; Smith DM; Moore DJ; Woods SP;
    J Neurovirol; 2013 Feb; 19(1):65-74. PubMed ID: 23250704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
    Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK
    Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
    Watson CW; Paolillo EW; Morgan EE; Umlauf A; Sundermann EE; Ellis RJ; Letendre S; Marcotte TD; Heaton RK; Grant I
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):56-64. PubMed ID: 31809361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons.
    Marquine MJ; Sakamoto M; Dufour C; Rooney A; Fazeli P; Umlauf A; Gouaux B; Franklin D; Ellis R; Letendre S; Cherner M; Heaton RK; Grant I; Moore DJ;
    J Neurovirol; 2016 Aug; 22(4):442-54. PubMed ID: 26679535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in neurocognitive screening among adults living with HIV in China.
    Qiao X; Lin H; Chen X; Ning C; Wang K; Shen W; Xu X; Xu X; Liu X; He N; Ding Y
    J Neurovirol; 2019 Jun; 25(3):363-371. PubMed ID: 30758812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Marquine MJ; Montoya JL; Umlauf A; Fazeli PL; Gouaux B; Heaton RK; Ellis RJ; Letendre SL; Grant I; Moore DJ;
    Clin Infect Dis; 2016 Sep; 63(5):694-702. PubMed ID: 27199461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.